Niagen Bioscience Partners With OneSpaWorld For Cruise Ship Clinics

MT Newswires Live03-31

Niagen Bioscience (NAGE) said Tuesday it partnered with wellness provider OneSpaWorld (OSW) to supply its intravenous cellular vitality treatments to more than 80 onboard medical spas.

The therapy is engineered to elevate target blood levels faster than conventional alternatives while reducing infusion durations by 75% without typical severe adverse reactions, the company said.

The 500-milligram doses are sourced through a US Food and Drug Administration-registered outsourcing facility to align with maritime regulatory requirements, Niagen Bioscience said.

Shares of the company were up over 5% in Tuesday trading.

Price: 4.53, Change: +0.25, Percent Change: +5.84

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment